Brazil governors to buy Covid-19 vaccines directly due to slow federal rollout
Governors are frustrated with the Bolsonaro administration’s failure to secure timely supplies of vaccines. . Read more at straitstimes.com.
Source: straitstimes.com
Page 5 - Fernando Marques News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Fernando Marques. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Fernando Marques Today - Breaking & Trending Today
Brazil governors to buy vaccines directly due to slow ...
HEALTH-CORONAVIRUS/BRAZIL (PIX): Brazil governors to buy vaccines directly due to slow federal rollout
Source: trust.org
Brazil maker of Sputnik V vaccine sees greenlight on tests by next week - Brazilian-American Chamber of Commerce
BRASILIA (Reuters) – The Brazilian pharmaceutical company that will make Russia’s Sputnik V vaccine against COVID-19 expects regulatory approval for Phase III tests by this week or early next at the latest, its Chief Executive Officer Fernando Marques said on Tuesday. Marques said the strong efficacy results from late stage trials in Russia, published on Tuesday by The Lancet – 91.6% effective against symptomatic COVID-19 – will help speed up approval in Brazil sought by his firm União Quimica.
Source: brazilcham.com
Brazil maker of Sputnik V vaccine sees greenlight on tests by next week
The Brazilian pharmaceutical company that will make Russia's Sputnik V vaccine against COVID-19 expects regulatory approval for Phase III tests by this week or early next at the latest, its Chief Executive Officer Fernando Marques said on Tuesday.
Source: reuters.com
Brazilian Maker of Sputnik V Vaccine Foresees Approval of Tests by Next Week
[uam_ad id="317182"] RIO DE JANEIRO, BRAZIL - The Brazilian pharmaceutical company that will make Russia’s Sputnik V vaccine against COVID-19 expects regulatory approval for Phase III tests by this week or early next week at the latest, Chief Executive Officer Fernando Marques said on Tuesday, February 2nd. Marques said the strong efficacy results from late stage trials in Russia, published on Tuesday by The Lancet - 91.6% effective against symptomatic COVID-19 - will help speed up approval in Brazil sought by his firm Subscribe to our Premium Membership Plan. Already Subscribed? Login Here
Source: riotimesonline.com